Summary
Although oral MTX for the treatment of RA has been shown to be effective, adverse events may lead to discontinuation of treatment. This study reports the 24-week comparison of the safety and efficacy of subcutaneous (sc) vs orally administered MTX in patients with active RA.
- rheumatoid arthritis clinical trials
- © 2006 MD Conference Express
Tools
The Clinical Efficacy and Safety of Subcutaneous Oral Application of Methotrexate in Patients with Active Rheumatoid Arthritis — Results of a Randomized, Controlled, Double-Blind, Multi-Center Study
Permalink:
Table of contents
Cited By...
- No citing articles found.